InstaNatural Expands 5-Star Vitamin C Skincare Line with Broad Spectrum SPF Products
September 24, 2024 08:04 ET
|
InstaNatural
InstaNatural is expanding its popular Vitamin C-infused skincare line to include three new suncare products.
Milestone Pharmaceuticals to Host Investor KOL Event
September 24, 2024 08:00 ET
|
Milestone Pharmaceuticals Inc.
Learnings from the Field: Managing PSVT and Studying AFib-RVR in the Community Setting Hosted 10 am ET, Tuesday, October 8, 2024 MONTREAL and CHARLOTTE, N.C., Sept. 24, 2024 (GLOBE...
Chinese "Dragon City" Tongliang dances across time, globe
September 13, 2024 07:03 ET
|
Chongqing Municipal Government Information Office
CHONGQING, China, Sept. 13, 2024 (GLOBE NEWSWIRE) -- In the first half of this year, Tongliang has achieved a comprehensive tourism revenue of 7.46 billion yuan, a year-on-year increase of 14.1...
Farmer Brothers reports fourth quarter and full year fiscal 2024 financial results
September 12, 2024 16:05 ET
|
Farmer Bros. Co.
Farmer Bros. Co. (NASDAQ: FARM) reports its fourth quarter and full year fiscal 2024 financial results for the period ended June 30, 2024.
Mini Spray Bottles Market Set to Reach USD 2.7 Billion by 2031, Driven by Growing Demand for Portable and Customizable Packaging Solutions | Future Market Insights, Inc.
September 10, 2024 06:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The global mini spray bottles market is poised for significant expansion, with forecasts indicating a rise from USD 1.6 billion in 2021 to an...
Avalyn Presents Multiple Posters on AP01 for Pulmonary Fibrosis, Including MIST Phase 2b Trial Design and ATLAS Phase 1b Study Post-hoc Analyses, at ERS 2024
September 08, 2024 09:00 ET
|
Avalyn Pharma Inc.
Trial Design Showcased for the MIST Study, a Recently Initiated Phase 2b Clinical Trial, Evaluating the Efficacy and Safety of AP01 (inhaled pirfenidone) Compared to Placebo in Patients with...
Milestone Partner Ji Xing Pharmaceuticals Ltd Announces Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
September 06, 2024 07:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...
Inhalation CDMO Market Poised for Significant Expansion, projected to Hit USD 14,863.6 Million by 2034 with a 5.7% of CAGR | Future Market Insights, Inc.
September 05, 2024 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The global inhalation CDMO market is set for robust expansion over the next decade. According to recent projections, the market is expected to grow at...
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
September 04, 2024 08:00 ET
|
Milestone Pharmaceuticals Inc.
MONTREAL and CHARLOTTE, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...
Global Body Mist Market Size To Worth USD 12.6 Billion By 2033 | CAGR Of 5.05%
September 04, 2024 03:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Global Body Mist Market is to Grow from USD 7.7 Billion in 2023 to USD 12.6 Billion By 2033, at a Compound Annual Growth Rate (CAGR)...